Arax Advisory Partners’s Dentsply Sirona XRAY Stock Holding History

Arax Advisory Partners’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$800K	Buy	+75,424	New	+$824K	0.01%	1336
2026 Q1	–	Sell	-533	Closed	-$6.09K	–	4386
2025 Q4	$6.09K	Sell	533 -232,798	-100%	-$2.73M	﹤0.01%	2743
2025 Q3	$2.96M	Buy	233,331 +233,175	+149,471%	+$3.38M	0.04%	361
2025 Q2	$2.48K	Hold	156	–	–	﹤0.01%	2490
2025 Q1	$2.33K	Sell	156 -4,451	-97%	-$78.9K	﹤0.01%	2024
2024 Q4	$87.4K	Buy	4,607 +4,511	+4,699%	+$95.4K	0.01%	715
2024 Q3	$2.6K	Buy	+96	New	+$2.45K	﹤0.01%	1965
2022 Q4	–	Sell	-1,000	Closed	-$28K	–	1353
2022 Q3	$28K	Buy	+1,000	New	+$34.2K	﹤0.01%	520
2018 Q3	–	Sell	-164	Closed	-$7K	–	744
2018 Q2	$7K	Sell	164 -63	-28%	-$2.96K	﹤0.01%	372
2018 Q1	$11K	Buy	+227	New	+$13.4K	0.01%	324
2017 Q3	–	Sell	-24	Closed	-$2K	–	500
2017 Q2	$2K	Hold	24	–	–	﹤0.01%	474
2017 Q1	$1K	Hold	24	–	–	﹤0.01%	524
2016 Q4	$1K	Buy	+24	New	+$1.42K	﹤0.01%	537

Other funds holding XRAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Arax Advisory Partners's XRAY Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Dentsply Sirona (XRAY) in Q2 2026: 75,424 shares worth $800K. The stake represents 0.01% of the portfolio and ranks #1336 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in XRAY as recently as Q4 2025.

Arax Advisory Partners first reported a position in XRAY in Q4 2016 and has held it in 13 quarters since. The position peaked at $2.96M in Q3 2025. 375 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

Arax Advisory Partners held 75,424 shares of Dentsply Sirona worth $800K as of Q2 2026.
Dentsply Sirona was a new Arax Advisory Partners position in Q2 2026.
Dentsply Sirona made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1336 holding.
Arax Advisory Partners first reported a position in Dentsply Sirona in Q4 2016 and has held it in 13 quarters since.
Arax Advisory Partners's Dentsply Sirona position peaked at $2.96M in Q3 2025.
375 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.